Crosscheck

Your medical. Crosschecked.

Check another medication

Pain

Chondroitin + glucosamine sulfate

Viscoelastic + Supplement
Other names: Osteo Bi-Flex

FAA guidance

Acceptable in the FAA document cited.

Source: FAA, MedGuide (FAA Office of Aerospace Medicine medication reference). FAA date 1 October 2026. Checked by Crosscheck 14 October 2026

The FAA's MedGuide lists chondroitin + glucosamine sulfate (Osteo Bi-Flex) as allowed, for osteoarthritis or supplement, with no wait after the first dose, after later doses or after the final dose, used per label directions.

Track your medications
More detail: chondroitin + glucosamine sulfateThe rest of Crosscheck's reading, in plain wordsOpen

The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.

Show the FAA's words: chondroitin + glucosamine sulfateThe official FAA wording: three passages, each with its document and dateOpen
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
Generic: chondroitin + glucosamine sulfate
Brand Name: Osteo Bi-Flex
Drug Class: Viscoelastic + Supplement
Underlying Condition: Osteoarthritis; Supplement
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: Per label directions
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.
Sources and dates: chondroitin + glucosamine sulfateOne FAA document, with the FAA's date and when Crosscheck checked itOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.